ITGB2 and neoplasm: Regarding the non-tumor disorders, studies suggested that the upregulated mRNA expression level of ITGB2 in PBMCs (peripheral blood mononuclear cells) did not associate with disease severity of SSc patients, nor did the status in premature infants with NEC [36,37].